These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9884277)

  • 21. Induction of hyporesponsiveness to fully allogeneic cardiac grafts by intratracheal delivery of alloantigen.
    Shirasugi N; Ikeda Y; Akiyama Y; Matsumoto K; Hamano K; Esato K; Bashuda H; Yagita H; Okumura K; Takami H; Kodaira S; Niimi M
    Transplantation; 2001 Feb; 71(4):561-4. PubMed ID: 11258436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of thymus to maintain operational tolerance to fully allogeneic cardiac grafts.
    Niimi M; Shirasugi N; Ikeda Y; Kan S; Takami H; Hamano K
    Ann Thorac Surg; 2001 Sep; 72(3):735-9. PubMed ID: 11565650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathymic administration of B cells induces prolonged survival of fully allogeneic cardiac grafts without prolonged deletion of donor-specific thymocytes.
    Niimi M; Jones ND; Pajaro OB; Morris PJ; Wood KJ
    Transpl Immunol; 1998 Sep; 6(3):177-81. PubMed ID: 9848224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The smell of Tokishakuyaku-san (TJ-23) induces generation of regulatory T cells and prolongation of survival of fully allogeneic cardiac grafts in mice.
    Jin X; Uchiyama M; Zhang Q; Watanabe T; Niimi M
    Transplant Proc; 2012 May; 44(4):1070-2. PubMed ID: 22564627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major histocompatibility complex-specific prolongation of murine skin and cardiac allograft survival after in vivo depletion of V beta+ T cells.
    Goss JA; Pyo R; Flye MW; Connolly JM; Hansen TH
    J Exp Med; 1993 Jan; 177(1):35-44. PubMed ID: 8418207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
    Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
    J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
    Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
    Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
    Saitovitch D; Morris PJ; Wood KJ
    Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
    Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells.
    Darby CR; Morris PJ; Wood KJ
    Transplantation; 1992 Sep; 54(3):483-90. PubMed ID: 1384184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection.
    Bumgardner GL; Li J; Prologo JD; Heininger M; Orosz CG
    Transplantation; 1999 Aug; 68(4):555-62. PubMed ID: 10480416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody.
    Pearson TC; Madsen JC; Larsen CP; Morris PJ; Wood KJ
    Transplantation; 1992 Sep; 54(3):475-83. PubMed ID: 1384183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
    J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
    Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
    Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of graft prolongation by mixed lymphocyte culture following anti-CD4 monoclonal antibody treatment among different donor-recipient combinations.
    Hamano K; Ito H; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Esato K
    Surg Today; 1999; 29(9):868-73. PubMed ID: 10489127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of donor-specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor MHC class I antigens.
    Oluwole SF; Chowdhury NC; Fawwaz RA
    Transplantation; 1993 Jun; 55(6):1396-402. PubMed ID: 8516825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of donor splenocytes via the respiratory tract generates CD8α
    Iwami D; Aramaki O; Shinohara N; Niimi M; Shirasugi N
    Transpl Immunol; 2018 Oct; 50():60-67. PubMed ID: 29990543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
    J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.